CN104645245B - 一种用于女性更年期抑郁药物制剂的制备方法 - Google Patents
一种用于女性更年期抑郁药物制剂的制备方法 Download PDFInfo
- Publication number
- CN104645245B CN104645245B CN201510110946.8A CN201510110946A CN104645245B CN 104645245 B CN104645245 B CN 104645245B CN 201510110946 A CN201510110946 A CN 201510110946A CN 104645245 B CN104645245 B CN 104645245B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- depression
- root
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract description 9
- 230000009245 menopause Effects 0.000 title abstract 3
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 210000000582 semen Anatomy 0.000 claims abstract description 10
- 241000628997 Flos Species 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 241000218176 Corydalis Species 0.000 claims abstract description 6
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 6
- 241000096284 Gynochthodes officinalis Species 0.000 claims abstract description 5
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 5
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 4
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 4
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 4
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 4
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 4
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 4
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 4
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 4
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 4
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 4
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 4
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 4
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 4
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 4
- 240000000249 Morus alba Species 0.000 claims abstract description 4
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 4
- 241000208966 Polygala Species 0.000 claims abstract description 4
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 4
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 4
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 4
- 235000018905 epimedium Nutrition 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 9
- 229940126062 Compound A Drugs 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000000643 oven drying Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 244000183685 Citrus aurantium Species 0.000 claims description 4
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 4
- 241000157352 Uncaria Species 0.000 claims description 4
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 241000213006 Angelica dahurica Species 0.000 claims description 3
- 240000007371 Cuscuta campestris Species 0.000 claims description 3
- 244000150195 Cyperus longus Species 0.000 claims description 3
- 235000018109 Cyperus longus Nutrition 0.000 claims description 3
- 244000075634 Cyperus rotundus Species 0.000 claims description 3
- 241000893536 Epimedium Species 0.000 claims description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 3
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 3
- 244000182216 Mimusops elengi Species 0.000 claims description 3
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 3
- 244000248825 Peltandra virginica Species 0.000 claims description 3
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 3
- 241000405414 Rehmannia Species 0.000 claims description 3
- 235000005010 Scirpus paludosus Nutrition 0.000 claims description 3
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 3
- 235000011477 liquorice Nutrition 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 2
- 240000000559 Albizia odoratissima Species 0.000 claims 1
- 235000011438 Albizia odoratissima Nutrition 0.000 claims 1
- 241000382455 Angelica sinensis Species 0.000 claims 1
- 241001080798 Polygala tenuifolia Species 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 238000010992 reflux Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 13
- 238000000034 method Methods 0.000 abstract description 5
- 239000002775 capsule Substances 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000003826 tablet Substances 0.000 abstract description 2
- 240000004307 Citrus medica Species 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 241001016310 Epimedium grandiflorum Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 33
- 238000011282 treatment Methods 0.000 description 17
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 210000002216 heart Anatomy 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 6
- 208000019901 Anxiety disease Diseases 0.000 description 5
- 230000036506 anxiety Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 4
- 229940126680 traditional chinese medicines Drugs 0.000 description 4
- 206010011469 Crying Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000008451 emotion Effects 0.000 description 3
- 230000020796 long term synaptic depression Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 208000020401 Depressive disease Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000001430 anti-depressive effect Effects 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 229940005513 antidepressants Drugs 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 230000002996 emotional effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- -1 fluvoxamide Chemical compound 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 208000024714 major depressive disease Diseases 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 2
- 230000009278 visceral effect Effects 0.000 description 2
- IGLYMJRIWWIQQE-QUOODJBBSA-N (1S,2R)-2-phenylcyclopropan-1-amine (1R,2S)-2-phenylcyclopropan-1-amine Chemical compound N[C@H]1C[C@@H]1C1=CC=CC=C1.N[C@@H]1C[C@H]1C1=CC=CC=C1 IGLYMJRIWWIQQE-QUOODJBBSA-N 0.000 description 1
- CHZJRGNDJLJLAW-RIQJQHKOSA-N (8r,9s,13s,14s,16r,17r)-3-cyclopentyloxy-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-16,17-diol Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1C[C@@H](O)[C@@]4(O)C#C)C)CC2=CC=3OC1CCCC1 CHZJRGNDJLJLAW-RIQJQHKOSA-N 0.000 description 1
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000020925 Bipolar disease Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- HCYAFALTSJYZDH-UHFFFAOYSA-N Desimpramine Chemical compound C1CC2=CC=CC=C2N(CCCNC)C2=CC=CC=C21 HCYAFALTSJYZDH-UHFFFAOYSA-N 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 206010049119 Emotional distress Diseases 0.000 description 1
- 206010016948 Food interaction Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 229940123685 Monoamine oxidase inhibitor Drugs 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- PHVGLTMQBUFIQQ-UHFFFAOYSA-N Nortryptiline Chemical compound C1CC2=CC=CC=C2C(=CCCNC)C2=CC=CC=C21 PHVGLTMQBUFIQQ-UHFFFAOYSA-N 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 206010031127 Orthostatic hypotension Diseases 0.000 description 1
- RMUCZJUITONUFY-UHFFFAOYSA-N Phenelzine Chemical compound NNCCC1=CC=CC=C1 RMUCZJUITONUFY-UHFFFAOYSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- DZGWFCGJZKJUFP-UHFFFAOYSA-N Tyramine Natural products NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 229940127085 adjuvant medication Drugs 0.000 description 1
- 230000000561 anti-psychotic effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 208000028683 bipolar I disease Diseases 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 229960003914 desipramine Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002898 effect on depression Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 201000003104 endogenous depression Diseases 0.000 description 1
- 229960002464 fluoxetine Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229950007863 nilestriol Drugs 0.000 description 1
- 229960001158 nortriptyline Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 229960000964 phenelzine Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 231100000175 potential carcinogenicity Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000009951 qiqi Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 229960002073 sertraline Drugs 0.000 description 1
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000021259 spicy food Nutrition 0.000 description 1
- 230000005982 spleen dysfunction Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229960003741 tranylcypromine Drugs 0.000 description 1
- 229960003732 tyramine Drugs 0.000 description 1
- DZGWFCGJZKJUFP-UHFFFAOYSA-O tyraminium Chemical compound [NH3+]CCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-O 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 208000037911 visceral disease Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
| 组别 | 例次 | 痊愈 | 显著进步 | 进步 | 无效 | 总有效率(%) |
| 治疗组 | 51 | 21 | 15 | 11 | 4 | 92 |
| 对照组 | 51 | 15 | 12 | 6 | 18 | 65 |
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510110946.8A CN104645245B (zh) | 2015-03-15 | 2015-03-15 | 一种用于女性更年期抑郁药物制剂的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510110946.8A CN104645245B (zh) | 2015-03-15 | 2015-03-15 | 一种用于女性更年期抑郁药物制剂的制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104645245A CN104645245A (zh) | 2015-05-27 |
| CN104645245B true CN104645245B (zh) | 2017-11-10 |
Family
ID=53237214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510110946.8A Active CN104645245B (zh) | 2015-03-15 | 2015-03-15 | 一种用于女性更年期抑郁药物制剂的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104645245B (zh) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1850234A (zh) * | 2006-02-24 | 2006-10-25 | 石圣洪 | 妇宁康薄膜衣片及其制备方法 |
| CN103479783A (zh) * | 2013-09-04 | 2014-01-01 | 上海中医药大学附属岳阳中西医结合医院 | 一种治疗更年期抑郁症的中药组合物及其应用 |
| CN104274789A (zh) * | 2014-11-11 | 2015-01-14 | 李桂亮 | 一种治疗抑郁的中药组合物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5686936B2 (ja) * | 2006-11-14 | 2015-03-18 | 大正製薬株式会社 | γ−オリザノール可溶化液体組成物 |
-
2015
- 2015-03-15 CN CN201510110946.8A patent/CN104645245B/zh active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1850234A (zh) * | 2006-02-24 | 2006-10-25 | 石圣洪 | 妇宁康薄膜衣片及其制备方法 |
| CN103479783A (zh) * | 2013-09-04 | 2014-01-01 | 上海中医药大学附属岳阳中西医结合医院 | 一种治疗更年期抑郁症的中药组合物及其应用 |
| CN104274789A (zh) * | 2014-11-11 | 2015-01-14 | 李桂亮 | 一种治疗抑郁的中药组合物 |
Non-Patent Citations (1)
| Title |
|---|
| 更年饮治疗女子更年期综合征临床体会;肖梅艳等;《实用中西医结合临床》;20041031;第4卷(第5期);第25页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104645245A (zh) | 2015-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN116370556A (zh) | 一种活血祛瘀、益气安神的中药组合物及其制备方法 | |
| CN104491801A (zh) | 一种治疗急慢性胃炎的中药制剂及其制备方法 | |
| CN104922543A (zh) | 一种治疗闭经的药物组合物及其制备方法 | |
| CN104984297A (zh) | 一种药物组合物在制备治疗闭经药物中的用途 | |
| CN101129971B (zh) | 治疗妇女痛经、月经不调的中药组合物及其制备方法 | |
| KR20180126231A (ko) | 혼합 생약 추출물을 유효성분으로 함유하는 뇌신경 보호용 조성물 | |
| CN105796845A (zh) | 药物组合物在制备治疗女性更年期综合征药物中的用途 | |
| CN104645245B (zh) | 一种用于女性更年期抑郁药物制剂的制备方法 | |
| CN104306662A (zh) | 一种治疗神经衰弱的中药组合物及其制备方法 | |
| CN104435567A (zh) | 一种含绞股蓝的治疗痛风的中药组合物 | |
| CN104225507A (zh) | 一种治疗脑溢血所致的肢体麻痹和疼痛的中药 | |
| CN105617251B (zh) | 一种治疗抑郁症的中药组合物及其制备方法 | |
| CN113599475A (zh) | 一种治疗多囊卵巢综合征的温中补肾组合物及其制备方法与应用 | |
| CN105362630A (zh) | 一种治疗更年期综合症的药物组合物及其制备方法 | |
| CN104436049A (zh) | 一种治疗心脏病的中药组合物 | |
| CN105343675A (zh) | 一种治疗肥胖症的中药制剂及其制备方法 | |
| CN105477302A (zh) | 一种治疗失眠症的中药组合物及其制备方法 | |
| CN104645246B (zh) | 一种用于女性更年期抑郁的药物制剂 | |
| CN104352994A (zh) | 用于性功能障碍的药物制剂 | |
| CN103520684A (zh) | 一种降血糖的中药复合物 | |
| CN105288538A (zh) | 一种药物组合物用于制备治疗闭经药物中的用途 | |
| CN105343761A (zh) | 一种治疗心肌梗死的中药组合物及其制备方法 | |
| CN104491677A (zh) | 一种治疗性功能障碍药物的制备方法 | |
| CN104587323A (zh) | 一种治疗白癜风的中药组合物 | |
| CN114470130B (zh) | 一种治疗心脏神经官能症的中药组合物及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190415 Address after: 226100 No. 101, Nine Groups, Banqiao Village, Zhengyu Town, Haimen City, Nantong City, Jiangsu Province Patentee after: Haimen Chuanghao Industrial Design Co.,Ltd. Address before: 276300 Yinan County Psychological Rehabilitation Hospital, Linyi City, Shandong Province Patentee before: Chen Mingyou |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20231101 Address after: 150026 D10-08, Block A, Modern Commercial Logistics City, South China City, Daowai District, Harbin City, Heilongjiang Province Patentee after: Harbin Yuanxun Pharmaceutical Technology Co.,Ltd. Address before: 226100 No. 101, Nine Groups, Banqiao Village, Zhengyu Town, Haimen City, Nantong City, Jiangsu Province Patentee before: Haimen Chuanghao Industrial Design Co.,Ltd. |